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Abstract
We have re-investigated the role of the complement system and the non-opsonic pattern recognition receptors dectin-1
and dectin-2 in the recognition of fungal particles by inflammatory neutrophils, monocytes and macrophages. We have
used in vivo and ex vivo models to study the recognition and response of these cells: i) We confirm previous observations
regarding the importance of complement to neutrophil but not monocytic responses; ii) We show that dectin-1 is important
for driving inflammatory cell recruitment to fungal stimuli and that it biases the immediate inflammatory response to one
that favors neutrophil over monocyte recruitment; iii) We show that dectin-2 contributes to the physical recognition of
fungal particles by inflammatory monocytes/macrophages, but is also expressed on neutrophils, where we show it has the
potential to contribute to cellular activation; iv) Additionally, we show that serum-opsonization has the potential to interfere
with non-opsonic recognition of fungal particles by dectin-1 and dectin-2, presumably through masking of ligands.
Collectively these roles are consistent with previously described roles of dectin-1 and dectin-2 in driving inflammatory and
adaptive immune responses and complement in containing fungal burdens. This study emphasizes the importance of
heterogeneity of receptor expression across myeloid cell subsets in protective immune responses.
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Introduction
Neutrophils often only interact significantly with pathogens,
such as fungi, after opsonization [1], whereas monocytes do not
require opsonization [2]. Our studies of dectin-1 [3,4,5] demon-
strated an additional mechanism for fungal recognition by
neutrophils [5]. Both complement and dectin-1 can be considered
‘primary pathogen recognition systems’ in that they mediate the direct
interaction of pathogens with immune cells and are fundamental
to cellular processes such as phagocytosis. Without these systems,
responses of other pattern recognition receptors (e.g. Toll-like
receptors) are often impaired. In the mouse, dectin-1 seems to play
a role in the recognition of non-opsonized Candida albicans by
inflammatory cells and macrophages (MØ)2, but appeared re-
dundant in the killing of opsonized yeast [5].
C. albicans is one of the main causes of mycoses worldwide. As
with many fungal species, the cell wall is carbohydrate rich and
a plethora of potential immune receptors may contribute to the
immune recognition process [6]. We showed that complement C3
is important for the control of initial C. albicans burdens, but
complement seems dispensable for the induction of inflammatory
responses as C3-deficient mice exhibited enhanced inflammatory
mediator production during infection [7]. Dectin-1-deficiency is
associated with increased susceptibility to infection with C. albicans
[5], perhaps mostly via oral/gastrointestinal routes [8], and as
mentioned above this is associated with defective MØ recognition
of C. albicans and impaired initiation of anti-fungal inflammatory
responses [5,8]. The importance of dectin-1 in antifungal
responses is now highlighted in several experimental fungal
infection models [5,9,10], and the increased susceptibility of
dectin-1-deficient mice to C. albicans infections is supported by the
discovery of dectin-1-deficient humans with recurrent mucocuta-
neous candidiasis [11,12]. Notably, dectin-1-deficient mice in-
fected with C. albicans elicit normal adaptive immune responses as
illustrated by IFNc and IL-17 production by splenocytes [13].
Dectin-2 is another lectin primarily expressed by MØ and
dendritic cells (DC) and has specificity for ‘high-mannose’-like
structures [14,15,16]. Dectin-2 uses the FceRc-chain [17,18,19] to
signal via Syk, Card9 and MAPK dependent pathways, just like
dectin-1 [13,20,21,22]. Dectin-2 is important for the generation of
Th17-like adaptive immune response, and together with dectin-1
coordinates Th1-like responses [18]. The involvement of dectin-2
in Th17 development has subsequently been confirmed in dectin-
2-deficient mice, which display increased susceptibility to infection,
similar to that observed under IL17-deficiency [23]. However, the
susceptibility of these individual lectin-deficient mice to C. albicans
infection is relatively mild when compared to that presented with
Card9-deficiency, the common adapter signaling molecule for
these lectins [21]. This likely reflects the redundancies of these
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receptors in infectious models, but also the multiple other
receptors impacted by Card9 deficiency [21,24].
Thus, experimental data indicate a role for both complement
and dectin-1 in the recognition of fungi by neutrophils. Additional
roles for dectin-1 and for dectin-2 have been identified in the
generation of the adaptive immune response. It is logical that the
primary role of complement and dectin-1 in controlling fungal
numbers is mediated at least in part through neutrophils,
a principal cell of host defense in fungal infection. The relatively
mild impact of dectin-1-deficiency compared to C3-deficiency on
the growth of C.albicans in vivo [5,7] is indicative of the redundancy
of innate immune recognition systems in vivo, but as other data
from our laboratories has indicated, the study of gene-targeted
animals does not always reveal the role of a defined protein or
system in an immune response [13,18,25].
In this study, we have reassessed the role of dectin-1, dectin-2
and complement in fungal recognition and fungal-driven in-
flammation using in vivo and ex vivo analysis to determine the
contribution of these mechanisms to the host defense process. We
selected these effectors, as opposed to, for example, the
macrophage mannose receptor which appears to have a secondary
role in fungal recognition [26], as our study was focused on the
primary recognition events. We have characterized a higher-dose
model of zymosan peritonitis with the aim of establishing the role
of dectin-1 in the inflammatory process and being able to examine
the mechanisms used by inflammatory cells to respond to the
challenge. Zymosan peritonitis was chosen because it is self-
resolving and has been extensively used in the analysis of other
molecular systems. We provide evidence for a significant level of




OPTI-Modified Eagle’s Medium (OPTI-MEM), Fetal Calf
Serum (FCS) and Alexa-fluor405 and Pacific Orange labeling kits
were all obtained from Invitrogen. Fluorescein isothiocyanate
isomer I (FITC) was purchased from Sigma. The Phycolink
Peridinin-chlorophyll-protein complex (PerCP)-labeling kit was
obtained from Europa Bioproducts. The Fugene 6 transfection
reagent was obtained from Roche. Microscopy Hemacolour cell
stain was from Merck. Flow-cytometric counting beads were from
AbD Serotec. Unless otherwise stated, all generic reagents were
obtained from Sigma or Invitrogen. All reagents were used
according to manufacturer’s directions unless specified otherwise.
Mice, Primary Cells and Peritonitis
129S6/SvEv and 129S6/SvEv.Clec7a2/2 [5] mice were ob-
tained from our own colonies. To induce sterile peritonitis, mice
were injected intraperitoneally with 1 ml 2% (w/v) BIOgel
polyacrylamide beads (BIO-Rad) or 26107 zymosan (Molecular
Probes) particles in 100 ml of PBS usually up to 7 days prior to
peritoneal lavage. Inflammatory cells were collected after sacrifice
by peritoneal lavage with ice-cold 5 mM EDTA in PBS. Resident
peritoneal cells were similarly collected from naive animals. To
remove BIOgel particles from cell preparations the cells were
passed through 40 mm cell strainers (BD).
Fluorescent Labelling of Zymosan and C. albicans
Zymosan (Invitrogen) was labeled with either Alexa-Fluor405
(A405)-succinimidyl ester (Invitrogen) or FITC (Sigma) and live
C.albicans SC5314 was labeled with Pacific Orange succinimidyl
ester (Invitrogen) as previously described [27]. The labelled
Zymosan/C.albicans was then washed (3506g, 5 minutes) four
times with excess PBS or medium and resuspended in assay
medium for ready for use, including opsonization. C.albicans was
grown and serum opsonized as previously described [5]. Apart
from titrations indicated in the text, serum opsonisation was
achieved with 50% (v/v) mouse serum.
Flow-cytometry
Staining of cells for flow cytometry was performed according to
standard protocols at 4uC in the presence of 2 mM NaN3 as
previously described [4,25]. For intracellular TNF assays, resident
peritoneal cells were washed and plated in 96-well v-bottomed
plates (36105 cells/well) in 100 ml of RPMI1640, 10% (v/v) FCS,
50 U/ml penicillin, 50 mg/ml streptomycin, 2 mM L-glutamine
containing GolgiPlug (BD). Zymosan-Alexa Fluor 405 was added
(10 mg in 100 ml). Plates were incubated for 3 hours at 37uC in
a 5% CO2 incubator. The cells were resuspended and immedi-
ately fixed with 1% formaldehyde in PBS for 20 min at 4uC. Cells
were permeabilized for staining by including 0.5% saponin
(Sigma-Aldrich) in all blocking and washing buffers. Antibody
staining was performed according to the standard protocols with
this modification.
The following antibodies were used in this study: Ly-6G-PE/
PE-Cy7 (clone 1A8; BD); Ly-6B.2-PE/APC/FITC (clone 7/4;
AbD Serotec [28]); F4/80-PE/APC/Alexa Fluor 405 (clone Cl:
A3-1; AbD Serotec); Anti-dectin-2 (D2.11E4 [16]); anti-CD11b-
FITC (clone 5C6; AbD Serotec); anti-CD11b-APC or –APC-Cy7
(clone M1/70; BD biosciences); anti-dectin-1-Alexa Flour 647
(clone 2A11; Serotec); anti-TNF-APC (clone MP6-XT22; BD);
multiple-species adsorbed anti-rat IgG-PE (Jackson Immunochem-
icals); Isotype control were either produced in house, or obtained
from either BD or AbD Serotec. When secondary anti-rat
antibodies were used in mutli-colour flow-cytometry, samples
were subsequently blocked with 10% rat serum before staining
with additional rat antibodies.
Samples were acquired on a CyAn ADP Analyser (3 laser)
(Beckman-Coulter) and data was analyzed using Summit (Beck-
man-Coulter) or FlowJo (Treestar) software. Myeloid cell subsets
were identified as previously described [28,29]. In brief,
Neutrophils will identified as Ly-6G+Ly-6B.2+, eosinophils were
identified as F4/80+SSChigh [29], tissue resident MØ were
identified by a characteristic F4/80highCD11bhigh phenotype
[29,30]. In select experiments, only Ly-6G was used to identify
neutrophils (as indicated). At the 4 hour time point after zymosan
administration, Ly-6C+ monocytes were identified by their Ly-
6B.2+Ly-6G–F4/80low phenotype [28]. Fourteen to 18 hours after
inflammatory stimuli, early inflammation-associated monocytes
and MØ were identified after exclusion of eosinophils and residual
tissue resident MØ, by their Ly-6G–Ly-6B.2high/+ phenotype
[28,29,31]. The above mentioned-gating strategies do not in-
corporate the relatively low number of ‘DC-like’ cells, which have
a CD11b+F4/80+ phenotype [32]. During the time course
analyses, ‘‘Total Monocyte/MØ’’ were defined as F4/80low-
highCD11b+/high cells (after exclusion of eosinphils), a strategy that
would have included the relatively low number of ‘DC-like’ cells.
Retroviral Transduction of NIH3T3
NIH3T3 were retrovirally transduced using retroviral vectors
that had been packaged in phoenix cells as described in detail
elsewhere [33]. The retroviral vectors pMXs-IP:Fcer1g [18] and
the empty vector controls, pFBneo (Stratagene), pMXs-IP [34]
and pMXs-IZ [25,35], have been previously described. pMXs-
IZ:dectin-2 was generated by amplifying the dectin-2 coding
sequence (alpha isoform) by PCR using pFBneo:dectin-2-HA [16]
Fungal Particle Recognition by Inflammatory Cells
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as a template and the specific primers: 59-AAAGGAATTCCAC-
CATGGTGCAGGAAAGACAATC-39 59-AAGGAATTCA-
TAGGTAAATCTTCTTCATTTC-39. The PCR product was
digested and cloned into the pMXs-IZ vector using the Eco RI
restriction enzyme and sequence fidelity was confirmed by
sequencing (Central Biotechnology Services, Cardiff University
School of Medicine). After retroviral transduction of the cell lines
they were selected in antibiotics and subsequently maintained
under selection (Zeocin, Invitrogen): 400 mg/ml; Puromycin
(Sigma): 3 mg/ml). Expression of dectin-2, by the transduced cells
was confirmed by flow-cytometric analysis [16]. The retroviral
vector pFBneo:dectin-1-HA has also been reported previously [36]
and was used in conjunction with pFBneo to generate new cell
lines for this study in exactly the same way as described above
except using G418 (Invitrogen) at 400 mg/ml for selection of
transductants.
Ex vivo and in vitro Cell:Microbe Interaction and
Activation Assays
For the study of inflammatory cells, peritoneal cells were
harvested 16–18 hours after BIOgel injection. Cells were washed
with OptiMem, 10% (v/v) FCS, 50 units/ml penicillin, 50 mg/ml
streptomycin, 2 mM L-glutamine, 30 mM b-mercaptoethanol),
counted and then resuspended at 105 cells per 60 ml of medium
containing 39-(p-aminophenyl) fluorescein (APF) (5 mM) in a v-
bottomed 96 well plate. The cells were incubated at 37uC for 30
minutes to load the cells with APF. Next, 40 ml of stimulants (e.g.
26106 particles of zymosan or 26106 live C. albicans yeast)
diluted in medium were added to each well and the plate was
placed in a 37uC water bath for 15 minutes in a 5% CO2
incubator. During these incubations the plate was covered with
a sterile gas permeable plate cover. The cells were then
immediately put on ice. Cells were identified by immunostaining,
using a quick stain protocol [25].
When using anti-dectin-2 (D2.11E4 [16]) or its rat IgG2a
control (AbD Serotec) in blocking studies, the antibodies were
included at 10 mg/ml in the APF preincubation step and the
assays were otherwise conducted as described above.
For the analysis of the interaction of fluorescent zymosan with
NIH3T3 transductants, cells were plated in 24-well plates at
0.56104 cells per well in DMEM supplemented with 10% FCS
and penicillin/streptomycin. Next day, 108 zymosan-FITC
particles were resuspended in medium with various concentrations
of mouse serum (0, 2, 10, 50 and 100%) and incubated at 37uC for
30 min with frequent agitation. After a 3 washes with medium,
zymosan-FITC particles were resuspended and added to NIH3T3
transductants at 66107 particles per well in triplicates. Plates were
incubated at 37uC and 4uC for 30 min and then, washed three
times with ice-cold medium. Cells were kept on ice and scraped
just before FACS acquisition on a CyAn ADP Analyzer (see
above).
Statistical Analyses
Statistical analysis was conducted using GraphPad Prism with
the tests used indicated in the text where appropriate. Exact P
values are displayed or abbreviated with the following convention:
* =P,0.05; ** = P,0.01; *** =P,0.001.
Results
Characterisation of a ‘High-dose’ Zymosan Peritonitis
Model
First we examined the inflammatory kinetics of a single injection
of 26107 FITC-labeled zymosan particles in wild-type (129S6/
SvEv) mice. The fate of the zymosan particles was followed via the
FITC-labeling as exemplified in Figure 1A. The inflammatory
kinetic was typical of an acute self-resolving reaction with a rapid
peak in neutrophil numbers, which was associated with a marked
drop in the recoverable number of tissue resident MØ
(Figure 1B). However monocyte/MØ numbers were subsequent-
ly restored by influx of new cells as inflammation proceeded
(Figure 1B).
The neutrophils recruited during the early time points of the
response exhibited most association with zymosan particles
(Figure 1C). These zymosan-associated neutrophils often con-
tained multiple particles (Figure 1D). The association of
neutrophils and zymosan was already reduced by 18 hours post
injection suggestive of a decline in available zymosan (Figure 1C).
FITC-labelling of the newly recruited inflammatory monocytes
and MØ was poor during these early time points with maximal
association evident by day 3 (Figure 1C). Uptake of zymosan by
tissue resident MØ is discussed in more detail below.
In vivo Role of Dectin-1 in Zymosan Peritonitis and
Inflammatory Cell:Zymosan Recognition
To determine the role of dectin-1 in the induction of
inflammation in response to high doses of zymosan and the
clearance of zymosan by neutrophils we examined the response of
dectin-1-deficient (Clec7a2/2) mice 4 hours after intraperitoneal
administration of 26107 zymosan particles. Compared to the wild-
type controls, the dectin-1-deficient mice exhibited a defect in
neutrophil recruitment and an unexpected increase in monocyte
recruitment (Figure 2A). A ratio of the absolute counts of
neutrophils and monocytes demonstrated a clear bias in the
recruitment of these subsets between both groups of mice
(Figure 2B). The number of neutrophils associated with FITC-
zymosan was also significantly lower in the absence of dectin-1
although the number of FITC-zymosan associated monocytes was
not significantly altered (Figure 2C). Even though the number of
recoverable tissue resident MØ were low (,5% of the numbers in
naive mice) (Figure 2A), there were more dectin-1-deficient
resident MØ associated with zymosan than wild type cells
(Figure 2C). Since we have previously observed a robust
dectin-1-dependent IL-6 response at this time point, we again
assessed IL-6 production as a marker of cellular activation. The
IL-6 present in the peritoneal cavity was significantly reduced in
the dectin-1-deficient mice compared to the controls (Figure 2D).
Ex vivo Characterisation of Dectin-1 and Complement
Involvement in Fungal Recognition
The altered inflammatory process that occurred in the absence
of dectin-1 makes the interpretation of the in vivo studies, with
regards to the role of dectin-1 in neutrophil and monocyte
recognition of zymosan difficult. To overcome this we examined
the interaction of inflammatory neutrophils and monocyte/MØ ex
vivo. Inflammatory myeloid cells were recovered from the
peritoneal cavity after injection with BIOgel polyacrylamide
beads. BIOgel was used because the inflammatory response that
follows was not impaired by dectin-1-deficiency. The physical
interaction between the inflammatory leukocytes and fluores-
cently-labeled zymosan (A405) or live C. albicans (Pacific Orange)
was assessed by flow-cytometry after prior gating on neutrophils
(Ly-6G+Ly-6B.2+) and monocyte/MØ (Ly-6G–Ly-6B.2+) [28,29].
Examples of gated neutrophils are shown in Figure 3A.
Conversion of APF by products of the respiratory burst to
a fluorescent form only occurred in cells interacting with fungal
particles (Figure 3A). Inflammatory neutrophils (Neut) and
Fungal Particle Recognition by Inflammatory Cells
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Monocyte/MØ (Mono/MØ), both expressed CD11b and dectin-
1 as previously reported [4], but it was evident that inflammatory
monocyte/MØ expressed more of both (Figure 3B).
Both, inflammatory neutrophils and monocyte/MØ from
dectin-1-deficient mice exhibited a clear defect in the physical
interaction with non-opsonized zymosan particles when compared
to the wild-type mice (Figure 3C) (for specific data from
a representative experiment see supplemental Figure 1).
Recognition of non-opsonized zymosan by neutrophils was poor,
but was more efficient by the inflammatory monocyte/MØ
(supplemental Figure 1). When zymosan was opsonized with
mouse serum, neutrophil recognition was substantially increased
and dependence on dectin-1 for both cell types to interact with the
zymosan particles was reduced (Figure 3C, upper panels). Of
those cells that interacted with zymosan during the course of the
experiment, a subset triggered respiratory burst as measured by
APF conversion (Figure 3C, lower panels and Figure S1).
Dectin-1-deficient neutrophils were substantially impaired in their
Figure 1. Characterization of high dose zymosan peritonitis. A) Representative flow-cytometric density plots showing the recruitment of
inflammatory cells and the clearance of fluorescent (FITC)-labelled zymosan particles. The examples shown are taken from 18 hours after the
administration of zymosan. Cells were identified as described in the methods. The panel on the left shows the gating of Ly-6B+ cells, which includes
(right) Ly-6Ghigh neutrophils and Ly-6G2 monocytes and MØ. Both neutrophils and monocytes/MØ exhibit association with FITC-labeled zymosan at
this time point (right panel). B) Graphical representation of the number of neutrophils (left) and all types of monocyte (Mo) and MØ combined (right)
in the peritoneal cavity before and after acute zymosan peritonitis. n = 3 129S6/SvEv mice per group and is representative of 2 independent
experiments. Data is shown as mean6SEM and cells were isolated from naı¨ve animals (0 hours), and challenged mice 4, 18, 72 and 168 hours after
induction of peritonitis. C) Graphical representation of the percentage of neutrophils and Mo/MØ present that are associated with zymosan, scored
by flow-cytometry as indicated in (A) above. D) Photomicrograph, which is representative of neutrophils associated with zymosan in a 4 hour
inflammatory infiltrate. Those neutrophils that are associated tend to have multiple particles, but only represent a minority of the total neutrophils
present at this time (see (C) above).
doi:10.1371/journal.pone.0045781.g001
Figure 2. Characterization of high-dose zymosan peritonitis in Dectin-1-deficient mice. Wild type (closed circles) and dectin-1-deficient
(Clec7a2/2; open circles) 129S6/SvEv mice were injected intraperitoneally with 26107 zymosan particles and inflammatory infiltrates examined 4
hours later. A) Graphs showing the number of neutrophils, monocytes and residual tissue resident MØ (Res MØ) in the peritoneal cavity at this time.
B) Graphical representation of a ratio of the absolute neutrophil and monocyte counts in each individual mouse. C) Graphs showing the numbers of
those cells indicated in (A) above that are associated with FITC-zymosan. D) Quantification of IL-6 in the peritoneal lavage fluid of zymosan injected
mice. For A,C and D data were normalized and pooled from 2 (Res MØ and IL-6 analysis) and 3 (Neutrophil and monocyte analysis) independent
experiments. Each symbol represents an individual mouse. Horizontal lines denote medians. Data were analyzed by non-parametric Mann-Whitney U-
test.
doi:10.1371/journal.pone.0045781.g002
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ability to trigger this respiratory burst when non-opsonised
zymosan was used, but exhibited little evidence of a defect when
opsonised zymosan was used (Figure 3C, lower left panel).
Dectin-1-deficient inflammatory monocyte/MØ only exhibited
a minor defect in their ability to trigger a respiratory burst when
interacting with zymosan (either opsonized or non-opsonized)
(Figure 3C, lower right panel), but notably the presence or
absence of opsonization had little effect on these cells.
The results obtained with live C. albicans were broadly consistent
with those obtained with zymosan (Figure 3C). The main
difference appeared to be a lower dependence on dectin-1 for
triggering the respiratory burst in neutrophils in the absence of
opsonization, once a physical interaction had occurred (Fig-
ure 3C, lower left panel). Similarly though, there was little
dependence on serum opsonization for the respiratory burst of
cells that had successfully interacted with the yeast particle/live C.
albicans. (Figure 3C, lower right).
Role of Dectin-2 in Inflammatory Cell Fungal Recognition
The other evident feature of the ability of the inflammatory cells
to interact with the yeast particles was that dependency on dectin-
1 was much less marked than has been observed with other
inflammatory MØ populations, such as thioglycollate-elicited MØ
[3,4,33]. Dectin-2 is transiently upregulated on inflammatory
monocyte/MØ [16]. To investigate whether this could contribute
to the alleviation of this dectin-1-dependency, we reassessed the
expression of dectin-2 (Figure 4A) and following treatment with
a blocking antibody (D2.11E4 [16,18]) before performing recog-
nition assays (Figure 4B). Low levels of dectin-2 surface
expression were observed on neutrophils when sensitive staining
protocols were adopted (Figure 4A). When anti-dectin-2 was
employed (using dectin-1-deficient cells to help unmask its
activity), we noted no effect on the recognition of zymosan by
neutrophils (Figure 4B upper panel), but a consistent reduction in
the recognition by inflammatory monocyte/MØ (Figure 4B,
upper panel). Data from a representative experiment can be in
Figure S2. For both cell types, the relative ability of the dectin-2-
blocked dectin-1-deficient cells that had recognized zymosan to
respond with ROS production was reduced when the zymosan
was not opsonized. (Figure 4B, lower panel).
We also considered that prior opsonization of yeast particles
with complement and other serum factors may in fact impair
recognition of yeast particles, by non-opsonic recognition systems.
For this purpose, we generated dectin-2 and FceRc-chain co-
expressing NIH3T3 fibroblasts to compare to dectin-1 expressing
NIH3T3 cells [36]. The heightened surface expression of dectin-2
in the presence of FceRc on these new cells was confirmed by flow
cytometry (Figure 5A). Subsequently, the ability of dectin-1 and
dectin-2-transduced NIH3T3 to recognize zymosan was studied
after 30 min incubations at 4uC and 37uC with or without prior
opsonization of the particles with increasing doses of serum
(Figure 5B). Increasing concentrations of serum used in the
opsonization of the zymosan particles resulted in reductions in the
engagement of both alternative non-opsonic pathogen recognition
systems.
Discussion
Zymosan and other fungal particles have been extensively used
in vivo to study acute inflammatory responses and the mechanisms
that control them. As part of our previous studies on dectin-1 we
examined the inflammatory responses to 105226106 live fungi or
yeast particles [5]. Typically, zymosan has been used intraperito-
neally in the 0.1–1 mg range for the study of peritonitis, which
roughly equates to 26107226108 particles, with some studies
using as much as 10 mg (,26109 particles). Increasing the
number of particles quickly overwhelms the resident tissue
phagocytes, invoking alternative inflammatory processes and
leaving ‘excess’ zymosan in the cavity to be cleared by the
recruited inflammatory cells. We have observed the impact of
different dosing regimens on the mechanism of the acute
inflammatory response when using more receptor-selective
reagents and this may also represent an artificial reliance upon
alternative inflammatory mechanisms in the absence of a primary
receptor [25]. Our previous studies identified a role for dectin-1 in
the activation of tissue resident phagocytes in response to fungal
challenge, which is associated with the production of inflammatory
mediators and the recruitment of inflammatory cells [5,25]. We
hypothesized that higher dosing regimens may have removed the
need for dectin-1 in the induction of the inflammatory response,
but it would also permit us to study the clearance of the residual
fungal particles directly by the inflammatory neutrophils and
monocytes.
Intraperitonal administration of 26107 zymosan particlesis
associated with an acute inflammatory response characterized by
disappearance of tissue resident MØ and influx of neutrophils and
monocytes. Initially, a significant proportion of neutrophils were
associated with multiple zymosan particles, but inflammatory
monocyte numbers were low during this period and showed
minimal interaction with zymosan particles. Peak zymosan
association with inflammatory MØ was observed later in the
inflammatory response after 3 days. Whilst only a small subset of
these cells interacted with zymosan the cells tended to contain
multiple particles. Given the kinetics of this interaction, it is
conceivable that these MØ acquire zymosan through ingestion of
apoptotic neutrophils or alternatively may represent the persis-
tence of a small number of tissue resident MØ late in the
inflammatory reaction [30,37].
Figure 3. Ex vivo recognition of yeast particles and live fungi by inflammatory cells. A) Representative flow-cytometric analysis, gated on
Ly-6G+ neutrophils, after coincubation of BIOgel-elicited inflammatory cells from wild type or dectin-1-deficient (Clec7a2/2) 129S6/SvEv interaction
with serum-opsonized or non-opsonized zymosan. Positive staining for the A405-labelled zymosan identifies the neutrophils that are associated
zymosan and only these cells exhibit conversion of APF, the ROS reporter. B) Representsative flow-cytometric analysis of CD11b and dectin-1
expression by inflammatory neutrophils and monocyte/MØ. Data represents specific receptor staining (shaded histograms) and isotype control
staining (bold lines). Data representative of 2 independent experiments and consistent with previous experiments with thioglycollate. C)
Inflammatory cells were loaded with APF and then incubated with serum-opsonized or non-opsonized A405-labelled zymosan or Pacific Orange-
labelled C. albicans for 15 minutes. After this time the association of the inflammatory cells with zymosan was measured by flow-cytometry (upper
panels) and in those cells that were interacting with zymosan the evidence for fluorescent conversion of APF was also quantified (lower panels). Data
is derived from three independent experiments and the data derived from the use of dectin-1-deficient cells is shown relative to wild type cells
(100%) as mean695% confidence interval (raw representative data from one of the 3 independent experiments are shown in the Figure S1). The
impact of complement osponization (‘C’) and the use of different fungal particle used (‘F’) were assessed by Two-way ANOVA (‘I’ = Interaction
statistic). Samples in which the 95% confidence intervals do not overlap with the mean wildtype are specific indicated with a# symbol. Differences in
impairment of response observed with dectin-1-deficient cells were further analysed by Bonferroni post-tests. P values derived from individual
Bonferroni post-tests are indicated with bracketed pairs of samples.
doi:10.1371/journal.pone.0045781.g003
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Studies in Dectin-1-deficient mice showed that dectin-1 was
important for the recruitment of neutrophils in both high (26107
particles) and low dose [5] zymosan peritonitis. Interestingly, the
dependency of inflammatory monocyte recruitment on dectin-1 in
the low dose studies [5] was lost in these higher dose studies (this
manuscript) indicating that alternate mechanisms promote the
recruitment of monocytes in these circumstances and that dectin-1
is differentially important for neutrophil recruitment. This suggests
that dectin-1 may bias towards a neutrophilic response, which
could be assumed to favor fungal killing.
Figure 4. Assessment of dectin-2 function on inflammatory
cells. A) Flow-cytometric plots showing expression of dectin-2 on the
surface of inflammatory neutrophils (Ly-6G+) and monocyte/MØ (Ly-
6G2). Data is pre-gated on Ly-6B.2+ cells and is representative of results
obtained with pooled cells from 3 independent experiments. B)
Assessment of the impact of blockade of dectin-2 (D2.11E4) on the
recognition (upper graphs) and response to (lower graphs) zymosan of
inflammatory neutrophils and monocyte/MØ from dectin-1-deficient
mice. All bars show mean695% confidence intervals of dectin-2-
blocked cells relative to isotype control treated cells (100%, dotted line)
from 3 independent experiments (raw representative data, which
includes the isotype control data, from one of the 3 independent
experiments are shown in Figure S2). Data were analysed by two-way
ANOVA, two assess the differences caused by complement opsoniza-
tion (‘C’) or the use of different cell lineages (‘L’). Samples in which the
95% confidence intervals do not overlap with the mean isotype control
are specific indicated with a # symbol.
doi:10.1371/journal.pone.0045781.g004
Figure 5. Inhibition of dectin-1 and -2-mediated fungal
recognition by prior complement opsonization. A) Representa-
tive flow cytometric plots of dectin-2 surface expression on NIH3T3
retrovirally transduced with dectin-2 (left panel) and both dectin-2 and
FceRc chain (right panel). B) Serum-opsonization inhibits the recogni-
tion of zymosan by both dectin-1 and dectin-2. NIH3T3 retrovirally
transduced as indicated in the legend were incubated with zymosan
that had been pre-incubated with serum at increasing concentrations
and the interaction was monitored by flow cytometry. Data represents
the mean6SEM of triplicates from a representative of 2 independent
experiments. Data in (D) was analyzed by two-way ANOVA, with the
significant Interaction statistics demonstrating the reduced binding of
zymosan to the transduced cells after prior incubation with increasing
concentrations of serum.
doi:10.1371/journal.pone.0045781.g005
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Additionally, these studies indicated that dectin-1 contributed to
the recognition of fungal particles by in vivo elicited inflammatory
neutrophils and monocytes. The number of neutrophils recogniz-
ing yeast particles was lower with dectin-1-deficiency even though
there were less neutrophils and the number of inflammatory
monocytes associated with zymosan was similar even thought
there were more monocytes present. These data hint that dectin-1
was functionally active on both neutrophils and monocytes in vivo,
however, the markedly altered inflammatory context makes
confounds this conclusion so ex vivo studies were conducted to
address the role of dectin-1 on these cells. We reproducibly
observed a role for dectin-1 in the ex vivo recognition of and cellular
responses of inflammatory neutrophils to fungal particles, which
consistent with our previous study [5] and with expectations that
complement is a fundamental mediator of neutrophil recognition,
was more evident when the particle was non-opsonized.
The high dose of zymosan was associated with substantial
disappearance of tissue resident MØ in both strains. In spite of
this, the defective induction of IL-6 indicates that cellular
activation was still impaired. Lastly, the residual tissue MØ from
dectin-1-deficient mice that were associated with zymosan were
significantly increased. However, normally the peritoneal cavity of
a mouse has approximately 2246106 tissue resident MØ, many of
these are not recoverable during inflammation. Thus, since only
a minority of tissue resident MØ are recoverable, the proposal that
increased association between tissue resident MØ and fungal
particles in the absence of dectin-1 could be a consequence of
impaired clearance by inflammatory cells has the caveat that it
could be subject to a selective bias of assaying a small number of
residual cells. As expected, all of these observations are consistent
with multiple mechanisms underlying the inflammatory response
[5,38].
During the course of these studies, we observed low dectin-2
expression on the surface of neutrophils. In the absence of
complement, anti-dectin-2 slightly impacted on the response of
inflammatory dectin-1-deficient neutrophils to zymosan. However,
it did not affect the physical recognition process of neutrophils,
which in the absence of complement and dectin-1 was extremely
poor, consistent with this low surface expression of dectin-2 by
neutrophils. Interestingly, Li et al. recently reported the role of
dectin-1 in the activation of CD11b [39], our results are more
consistent with a minimal role for dectin-1 in neutrophil activation
by fungal particles, but this co-operative interaction could explain
the more pronounced role we have observed for dectin-1 in the
response to non-opsonised rather than opsonised fungal particles.
It seems likely that in vivo other factors would contribute to CD11b
activation, and it would be interesting in the light of these studies
to determine if dectin-2 and other lectins could substitute for
dectin-1.
Dectin-1-deficiency impaired the recognition of fungal particles
by inflammatory monocyte/MØ ex vivo. These inflammatory
monocytes exhibit an upregulation of dectin-2 expression [16] and
both bone marrow cultures in GM-CSF (suggested to be similar to
inflammatory monocyte derived cells [40]) and a cell line model
that resemble these cultures identify dectin-2 as a second receptor
for fungi alongside dectin-1 [18,35]. Blockade of dectin-2 in
dectin-1-deficient inflammatory monocyte/MØ further reduced,
although not completely, their ability to elicit zymosan-mediated
responses. Mincle [41,42] is another likely candidate that could
mediate this interaction, and like dectin-2 we have observed
transient upregulation of the mRNA encoding mincle on
inflammatory monocytes (data not shown). The fundamental role
played by surface lectins in the recognition of fungal particles by
inflammatory and tissue resident monocytic cells in conjunction
with the observed impact of select deficiencies on the adaptive
immune responses [5,13,18,23] raises questions about the
regulation of these events. Thus, the dependence on one receptor
over another, for example in driving Th17 responses [13,18],
could be governed by: i) selective expression of these receptors by
responding antigen presenting cell; ii) a selective display of ligands
by the pathogen; or iii) by subtle differences in the signaling
responses of these receptors.
Lastly, we considered that ‘excess’ in vitro complement
opsonization may compete with non-opsonic receptors (as a direct
competitive inhibitor). Prior in vitro opsonization of zymosan with
high concentrations of serum directly inhibited its ability to
interact with dectin-1 or dectin-2 transduced fibroblasts confirm-
ing this as a possibility. Our previous studies of dectin-1 ‘specific’
agents indicated that the converse also occurs, with rapid
clearance of a limited challenge by mononuclear phagocytes
restricting alternative inflammatory mechanisms [25], speculated
to be something like complement.
Collectively, these studies are consistent with the host response
to infection being reliant on the cellular heterogeneity and tissue
microenvironment at the site of infection and, perhaps critically,
the display of ligands by distinct morphologies of a pathogen and
the number of infecting organisms.
Supporting Information
Figure S1 Ex vivo recognition of yeast particles and live
fungi by inflammatory cells. A) Inflammatory cells were
loaded with APF and then incubated with serum-opsonized or
non-opsonized zymosan for 15 minutes. After this time the
association of the inflammatory cells with zymosan was measured
by flow-cytometry (upper panels) and in those cells that were
interacting with zymosan the evidence for fluorescent conversion
of APF was also quantified (lower panels). D) The experiments
shown in (C) were repeated with live pacific orange-labelled C.
albicans. Both (C) and (D) are representative experiments from 3
independent experiments and data shown represented the
mean6SEM of triplicates.
(TIF)
Figure S2 Assessment of dectin-2 function on inflam-
matory cells. Assessment of the impact of blockade of dectin-2
(D2.11E4) on the recognition (upper graphs) and response to
(lower graphs) zymosan of inflammatory neutrophils and mono-
cyte/MØ. Data represents mean6SEM of triplicates from
a representative of 3 independent experiments.
(TIF)
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